Results 121 to 130 of about 1,109 (148)
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability. [PDF]
Nat AgingTherriault J, Janelidze S, Benedet AL, Ashton NJ, Arranz Martínez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hyung Hong C, Roh HW, Contador J, Puig Pijoan A, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez-Arias J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson S, Pascoal TA, Gauthier S, Lleó A, Paquet C, Petersen RC, Salmon D, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Suárez-Calvet M, Jack CR, Blennow K, Hansson O, Rosa-Neto P. +55 moreeuropepmc +1 more sourceAmyloid-linked versus age-driven copathologies in Alzheimer’s dementia: differential associations with APOE ε4
Rodríguez-Baz Í, Vaqué-Alcázar L, Maure-Blesa L, Pertierra L, Martinez JA, Molina-Porcel L, Aldecoa I, Ferreira N, Paradela R, Videla L, Barroeta I, Carmona-Iragui M, Sánchez-Saudinós MB, Selma-González J, Dols-Icardo O, Aranha MR, Dolcet SS, Abdelnour C, Illán-Gala I, Alcolea D, Lleo A, Suemoto C, Fortea J. +22 moreeuropepmc +1 more sourceAssociations of lifestyle factors with amyloid pathology in persons without dementia. [PDF]
J Alzheimers DisOomens JE, Vos SJ, Maserejian NN, Boada M, Didic M, Engelborghs S, Fladby T, van der Flier WM, Frisoni GB, Fröhlich L, Gill KD, Grimmer T, Hort J, Itoh Y, Iwatsubo T, Klimkowicz-Mrowiec A, Landau SM, Lee DY, Lleó A, Martinez-Lage P, de Mendonça A, Meyer PT, Parchi P, Pardini M, Parnetti L, Popp J, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Sánchez-Juan P, Santana I, Scarmeas N, Scheltens P, Skoog I, Sperling RA, Stern Y, Villeneuve S, Waldemar G, Wiltfang J, Zetterberg H, Alcolea D, Allegri RF, Altomare D, Bateman RJ, Baiardi S, Baldeiras I, Blennow K, Braber AD, van Buchem MA, Byun MS, Cerman J, Chen K, Chipi E, Day GS, Drzezga A, Ekblad LL, Förster S, Fortea J, Freund-Levi Y, Frings L, Guedj E, Habeck CG, Handels R, Hausner L, Hellwig S, Jiménez-Bonilla JF, Juaristi AI, Kandimalla R, Kern S, Bordewick Kirsebom BS, Kornhuber J, Legdeur N, Levin J, Maier W, Marquié M, Minatani S, Morbelli SD, Mroczko B, Ntanasi E, de Oliveira CR, Orellana A, Peters O, Prabhakar S, Ramakers IH, Rodríguez-Rodriguez E, Ruiz A, Rüther E, Sakhardande J, Selnes P, Silva D, Soininen H, Spiru L, Takeda A, Teunissen CE, Tijms BM, Vermunt L, Wallin ÅK, Wiels W, Yannakoulia M, Yi D, Zettergren A, Alzheimer's Disease Neuroimaging Initiative (ADNI), A4 Study group, Dominantly Inherited Alzheimer Network (DIAN), European Prevention of Alzheimer's Dementia (EPAD) consortium, Fundació ACE Healthy Brain Initiative (FACEHBI), Japan Alzheimer's Disease Neuroimaging Initiative (J-ADNI), Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease (KBASE), Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) research group, Ossenkoppele R, Verhey FR, Visser PJ, Jansen WJ. +113 moreeuropepmc +1 more source
